110 related articles for article (PubMed ID: 2768543)
21. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
Feighner JP
J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
[TBL] [Abstract][Full Text] [Related]
22. Depression in children: relationship between plasma imipramine levels and response.
Preskorn SH; Weller EB; Weller RA
J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
[TBL] [Abstract][Full Text] [Related]
23. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
Nierenberg AA; Keck PE
J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant properties of trazodone.
Bryant SG; Ereshefsky L
Clin Pharm; 1982; 1(5):406-17. PubMed ID: 6764164
[TBL] [Abstract][Full Text] [Related]
25. Steady-state plasma levels during antidepressant therapy with amitriptyline and amitriptylinoxide.
Koch H
Isr J Psychiatry Relat Sci; 1990; 27(1):48-56. PubMed ID: 2194992
[TBL] [Abstract][Full Text] [Related]
26. Trazodone dosing regimen: experience with single daily administration.
Fabre LF
J Clin Psychiatry; 1990 Sep; 51 Suppl():23-6. PubMed ID: 2211561
[TBL] [Abstract][Full Text] [Related]
27. Desipramine plasma levels and response in elderly melancholic patients.
Nelson JC; Jatlow PI; Mazure C
J Clin Psychopharmacol; 1985 Aug; 5(4):217-20. PubMed ID: 4019810
[TBL] [Abstract][Full Text] [Related]
28. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
29. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of bupropion in elderly patients: preliminary observations.
Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
[TBL] [Abstract][Full Text] [Related]
31. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.
Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S
Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone.
Otani K; Mihara K; Yasui N; Ishida M; Kondo T; Tokinaga N; Ohkubo T; Osanai T; Sugawara K; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):239-44. PubMed ID: 9075270
[TBL] [Abstract][Full Text] [Related]
33. Effects of trazodone on the sleep of depressed subjects--a polygraphic study.
Mouret J; Lemoine P; Minuit MP; Benkelfat C; Renardet M
Psychopharmacology (Berl); 1988; 95 Suppl():S37-43. PubMed ID: 3133713
[TBL] [Abstract][Full Text] [Related]
34. Extended-release trazodone (Oleptro) for depression.
Med Lett Drugs Ther; 2010 Nov; 52(1351):91-2. PubMed ID: 21068704
[TBL] [Abstract][Full Text] [Related]
35. A study of serum levels of trazodone produced in man following single or repeated oral administrations.
Allori L; Catanese B; Cioli V; Interdonato N
Boll Chim Farm; 1978 Sep; 117(9):530-3. PubMed ID: 752360
[No Abstract] [Full Text] [Related]
36. [Plasma levels of metapramine and its 3 major metabolites in patients with depression. Results and preliminary interpretations].
Bougerol T; Gouezo F; Pok Phak Rop P; Valli M; Durand A; Conquy T; Scotto JC; Viala A
Encephale; 1990; 16(1):35-40. PubMed ID: 2328683
[TBL] [Abstract][Full Text] [Related]
37. Differential dosing of trazodone in elderly depressed patients: a study to investigate optimal dosing.
Mukherjee PK; Davey A
J Int Med Res; 1986; 14(5):279-84. PubMed ID: 3533676
[TBL] [Abstract][Full Text] [Related]
38. Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity.
Bertschy G; Vandel S; Vandel B; Allers G; Bechtel P; Volmat R
Pharmacopsychiatry; 1989 Jul; 22(4):161-4. PubMed ID: 2762378
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.
Fudge JL; Perry PJ; Garvey MJ; Kelly MW
J Affect Disord; 1990 Apr; 18(4):275-80. PubMed ID: 2140380
[TBL] [Abstract][Full Text] [Related]
40. Acute stimulant response prediction of chronic trazodone effects.
Little KY; Gay TL
Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):815-24. PubMed ID: 8870066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]